Flow Cytometry in Oncology: Some Lessons from History

  • Howard M. Shapiro
Part of the Developments in Oncology book series (DION, volume 77)


Although potential applications to cancer diagnosis, research, and treatment provided much of both the rationale and the funding for the early development of flow cytometry, a look back through the literature reveals that the field has not developed precisely as its pioneers envisioned. While flow cytometry is now widely used in oncology, reexamining some longstanding unsolved problems and neglected areas from the vantage point of the present may be helpful in broadening the scope of future applications.


Flow Cytometry Fluorescence Polarization Flow Cytometric Assay Multiparameter Flow Cytometry Leukemic Clone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Caspersson TO: Cell Growth and Cell Function, Norton, New York, 1950.Google Scholar
  2. 2.
    Papanicolaou GN, Traut HF: The diagnostic value of vaginal smears in carcinoma of the uterus. Am. J. Obst. Gynec. 42:193, 1941.Google Scholar
  3. 3.
    Mellors RC, Silver R: A microfluorometric scanner for the differential detection of cells: Application to exfoliative cytology. Science 114:356, 1951.PubMedCrossRefGoogle Scholar
  4. 4.
    Miner RW, Kopac MJ (eds): Cancer Cytology and Cytochemistry. Ann. N.Y. Acad. Sci., 63, 1956.Google Scholar
  5. 5.
    Kamentsky LA, Melamed MR, Derman H: Spectrophotometer: New instrument for ultrarapid cell analysis. Science 150:630, 1965.PubMedCrossRefGoogle Scholar
  6. 6.
    Koenig SH, Brown RD, Kamentsky LA, et al: Efficacy of a rapid cell spectrophotometer in screening for cervical cancer. Cancer 21:1019, 1968.PubMedCrossRefGoogle Scholar
  7. 7.
    Finkel GC, Grand S, Ehrlich MP, DeCote R: Cytologic screening automated by Cytoscreener, J. Assn. Adv. Med. Instrum. 4:106–110, 1970.Google Scholar
  8. 8.
    Evans DMD (ed): Cytology Automation. Livingstone, Edinburgh, 1970.Google Scholar
  9. 9.
    Dittrich W, Gohde W: Impuisfluorometrie bei einzelzellen in Suspensionen. Z. Naturforsch. 24b:360, 1969.Google Scholar
  10. 10.
    Van Dilla MA, Trujillo TT, Mullaney PF, Coulter JR: Cell microfluorometry: A method for rapid fluorescence measurement. Science 163:1213, 1969.PubMedCrossRefGoogle Scholar
  11. 11.
    Wheeless LL Jr: Slit-scanning. In: Flow Cytometry and Sorting, MR Melamed, T Lindmo, ML Mendelsohn (eds), Wiley-Liss, New York, pp. 103–125, 1990.Google Scholar
  12. 12.
    Steinkamp JA, Crissman HA: Automated analysis of deoxyribonucleic acid, protein, and nuclear-to-cytoplasmic relationships in tumor cells and gynocologic specimens. J. Histochem. Cytochem. 22:616–621, 1974.PubMedCrossRefGoogle Scholar
  13. 13.
    Steinkamp JA, Hansen KM, Wilson JS, Salzman GC: Automated analysis and separation of cells from the respiratory tract: Preliminary characterization studies in hamsters. J. Histochem. Cytochem. 25: 892–898, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Traganos F, Darzynkiewicz Z, Sharpless T, Melamed MR: Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J. Histochem. Cytochem. 25:46, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Barlogie B, Drewinko B, Schumann J, et al: Cellular DNA content as a marker of neoplasia in man. Amer. J. Med. 69:195, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Hedley DW, Friedlander ML, Taylor IW, et al: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31:1333, 1983.PubMedCrossRefGoogle Scholar
  17. 17.
    Klein FA, Herr HW, Whitmore WF Jr, et al: Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancer. Urology 17:310–314, 1981.PubMedCrossRefGoogle Scholar
  18. 18.
    Tobey RA, Crissman HA: Use of flow microfluorometry in detailed analysis of effects of chemical agents on cell cycle progression. Cancer Res. 32:2726, 1972.PubMedGoogle Scholar
  19. 19.
    Andreeff M (ed): Impulscytophotometrie. Springer, Berlin, 1975.Google Scholar
  20. 20.
    Gray JW, Dolbeare F, Pallavicini MG: Quantitative cell-cycle analysis. In: Flow Cytometry and Sorting, MR Melamed, T Lindmo, ML Mendelsohn (eds), Wiley-Liss, New York, pp. 445–467, 1990.Google Scholar
  21. 21.
    Darzynkiewicz Z, Traganos F, Melamed MR: New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1:98, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Gray JW, Mayall BH (eds): Monoclonal Antibodies Against Bromodeoxyuridine, Alan R. Liss, New York, 1985 (Also published as Cytometry Volume 6, Number 6).Google Scholar
  23. 23.
    Crissman HA, Steinkamp JA: A new method for rapid and sensitive detection of bromodeoxyuridine in DNA replicating cells. Exp. Cell Res. 173:256, 1987.PubMedCrossRefGoogle Scholar
  24. 24.
    Mariani BD, Slate DL, Schimke RT: S phase specific synthesis of dihydrofolate reductase in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 78:4985, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Rosowsky A, Wright J, Shapiro H, et al: A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance. J. Biol. Chem. 257:14162, 1982.PubMedGoogle Scholar
  26. 26.
    Krishan A, Ganapathi R: Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Cancer Res. 40:3895, 1980.PubMedGoogle Scholar
  27. 27.
    Lalande M, Ling V, Miller RG: Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc. Natl. Acad. Sci. USA 78:363–367, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Lampidis TJ, Munck J-N, Krishan A, Tapiero H: Reversal of resistance to rhodamine 12 3 in adriamycin-resistant Friend leukemia cells. Cancer Res. 45:2626–2631, 1985.PubMedGoogle Scholar
  29. 29.
    Kessel D, Beck WT, Kukuraga D, Schulz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51:4665–4670, 1991.PubMedGoogle Scholar
  30. 30.
    Krishan A, Sauerteig A, Stein JH: Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry 12:731–742, 1991.PubMedCrossRefGoogle Scholar
  31. 31.
    Hedley DW: Flow cytometric assays of anticancer drug resistance. Ann. N.Y. Acad. Sci. 677:340–353, 1993.CrossRefGoogle Scholar
  32. 32.
    Shapiro HM: Cell membrane potential analysis. Methods Cell. Biol. 33:25–35, 1990.PubMedCrossRefGoogle Scholar
  33. 33.
    Lampidis TJ, Bernai SD, Summerhayes IC, Chen LB: Selective toxicity of rhodamine 12 3 in carcinoma cells in vitro. Cancer Res. 43:716, 1983.PubMedGoogle Scholar
  34. 34.
    Bernai SD, Shapiro HM, Chen LB: Monitoring the effect of anti-cancer drugs on L1210 cells by a mitochondrial probe, rhodamine-123. Int. J. Cancer 30:219, 1982.CrossRefGoogle Scholar
  35. 35.
    Roper P, Drewinko B: Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res. 36:2182–2188, 1976.PubMedGoogle Scholar
  36. 36.
    Darzynkiewicz Z, Bruno S, Del Bino G, et al: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795–808, 1992.PubMedCrossRefGoogle Scholar
  37. 37.
    Cercek L, Cercek B, Ockey CH: Structuredness of the cytoplasmic matrix and Michaelis-Menten constants for the hydrolysis of FDA during the cell cycle in Chinese hamster ovary cells. Biophysik 10:187, 1973.PubMedCrossRefGoogle Scholar
  38. 38.
    Cercek L, Cercek B: Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: A review. Eur. J. Cancer 13:903, 1977.PubMedGoogle Scholar
  39. 39.
    Cercek L, Cercek B: Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by phytohaemagglutinin and cancer basic protein as measured on single cells. Brit. J. Cancer 33:359, 1976.CrossRefGoogle Scholar
  40. 40.
    Stewart S, Pritchard KI, Meakin JW, Price GB: A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer. Clin. Immunol. Immunopathol. 13:171, 1979.PubMedCrossRefGoogle Scholar
  41. 41.
    Miller RG, La Lande ME, McCutcheon MJ, et al: Usage of the flow cytometer-cell sorter. J. Immunol. Methods 47:13, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Udkoff R, Chan S, Norman A: Identification of mitogen responding lymphocytes by fluorescence polarization. Cytometry 1:265, 1981.PubMedCrossRefGoogle Scholar
  43. 43.
    Rolland JM, Dimitropoulos K, Bishop A, et al: Fluorescence polarization assay by flow cytometry. J. Immunol. Methods 76:1–10, 1985.PubMedCrossRefGoogle Scholar
  44. 44.
    Dimitropoulos K, Rolland JM, Nairn RC: Analysis of early lymphocyte activation events by fluorescence polarization flow cytometry. Immunol. Cell Biol. 66:253–260, 1988.PubMedCrossRefGoogle Scholar
  45. 45.
    Shapiro HM: Practical Flow Cytometry. 3rd Ed., Wiley-Liss (eds), New York, pp. 326–348 and 395–402, 1994.Google Scholar
  46. 46.
    Shapiro HM, Young RE, Webb RH, Wiernik PH: Multiparameter flow cytometric characterizations of cell populations in acute leukemia. Blood 50 Supp. 1: 209, 1977.Google Scholar
  47. 47.
    Terstappen LW, Loken MR: Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal. Cell. Pathol. 2:229–240, 1990.PubMedGoogle Scholar
  48. 48.
    Terstappen LW, Safford M, Konemann S, et al: Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 6:70–80, 1992.PubMedGoogle Scholar
  49. 49.
    Huang S, Terstappen LW: Formation of haematopoietic microenvironment and haemopoietic stem cells from single human bone marrow stem cells. Nature 360:745–749, 1992.PubMedCrossRefGoogle Scholar
  50. 50.
    Lowenberg B, Van Putten WLJ, Touw IP, et al: Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N. Engl. J. Med. 328:614–619, 1993.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Howard M. Shapiro

There are no affiliations available

Personalised recommendations